Cleveland Clinic Foundation; Cole Eye Institute

Cleveland, Ohio 44195-0001

2 studies enrolling now · 18 studies all time

What they study most

Age - Related Macular Degeneration (AMD), Age-Related Maculopathy, Cornea; Ectasia, Diabetic Macular Edema, Geographic Atrophy, Geographic Atrophy (GA), Keratoconus, Macular Degeneration, Macular Degeneration, Age-Related, Macular Edema, Non-Infectious Uveitis, Noninfectious Uveitis

Studies at this site

• Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD — Recruiting now
• Corneal Elastography and Patient Specific Modeling — Recruiting now
• Imaging Quantification of Inflammation (IQI) — Running, not enrolling
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema — Completed
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) — Stopped early
• A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration. — Stopped early
• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) — Completed
• A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) — Stopped early
• A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis — Stopped early
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO — Stopped early
• Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy — Completed
• A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema — Completed
• Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis — Completed
• A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) — Stopped early
• A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration — Completed
• Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis — Paused